Physician profile
John Mulvey
NPI 1902863509
$11,715.53
in general payments reported to CMS, 2019-2025
46 companies · $1,109 in 2025
The $1,109 reported for 2025 was more than what 88% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,484 · 2020: $1,818 · 2021: $2,148 · 2022: $1,656 · 2023: $1,428 · 2024: $1,072 · 2025: $1,109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,610.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,609.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,684.17 | 2019-2025 | Otezla, Repatha, Evenity |
| Astrazeneca Pharmaceuticals LP | $1,256.62 | 2019-2025 | Farxiga, Breztri, Fasenra |
| Novo Nordisk INC | $1,188.90 | 2019-2025 | Rybelsus, Ozempic |
| Lilly USA, LLC | $889.28 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $863.05 | 2019-2025 | Jardiance, Synjardy |
| Glaxosmithkline, LLC. | $855.56 | 2019-2024 | Trelegy Ellipta |
| Pfizer INC. | $821.40 | 2019-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $504.62 | 2019-2024 | Takhzyro, Trintellix |
| Allergan, INC. | $429.24 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $364.52 | 2019-2025 | Camzyos, Eliquis |
| Abbott Laboratories | $265.03 | 2021-2025 | Freestyle Libre 3, Proclaim |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $232.52 | 2020-2025 | Xifaxan, Trulance |
| Mylan Specialty L.P. | $214.89 | 2021-2023 | Yupelri |
| Abbvie INC. | $213.32 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $201.36 | 2021-2024 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Mulvey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.